Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan with over 120 years of innovation, is expanding its Australian presence. Our mission: to redefine cancer treatment through our proprietary antibody drug conjugate (ADC) technology, aiming to become a global top ten in oncology by 2030.
In Australia, we’re building a dedicated team, conducting 18 clinical trials at 47 sites evaluating our DXd ADCs*, and working to bring their benefits to patients sooner. Our pipeline of ADCs and novel entities targets difficult-to-treat cancers including breast, lung, gastric, ovarian, and endometrial. We are committed to partnering with researchers, clinicians, patients, patient advocates and government to deliver our mission.
*does not include other assets

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients. The Company’s focus is on some of the most challenging cancers. It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyse changes in the practice of medicine and transform the patient experience. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
For more information, please visit astrazeneca.com.au

Breast Surgeons of Australia and New Zealand (BreastSurgANZ) is the peak professional membership society representing specialist breast surgeons who manage benign and malignant breast disease across Australia and Aotearoa New Zealand. The Society sets and upholds post-Fellowship training standards and promotes excellence in patient care through education, quality audit, research, and the advancement of evidence-based surgical practice.
For more information please visit: www.breastsurganz.org

The Australasian Society for Breast Disease (ASBD) is a multidisciplinary society for health professionals with an interest in the prevention, diagnosis, treatment and research aspects of breast disease.
ASBD was incorporated in 1997 and in 2022 celebrated its 25th Anniversary. We welcome membership from all health professionals with an interest in the multidisciplinary approach to breast cancer.
VISION: Better breast health outcomes in Australia and New Zealand.
PURPOSE: We support health professionals to achieve better health outcomes
For more information please visit: www.asbd.org.au

At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers’ toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients’ lives for the better while enabling healthcare professionals to perform at their best. Because people, and their wellbeing, are at the heart of every scientific advancement we pursue. We partner closely with the brightest minds in healthcare to ensure that every solution we create melds the latest technology with compassion and empathy. Because at Solventum, we never stop solving for you.
For more information click here: Enabling better, smarter, safer healthcare | Solventum

GenesisCare is a proudly Australian-run cancer care provider, specialising in radiation therapy with a growing footprint in medical oncology, theranostics and personalised medicine. Our relentless pursuit for better care is reflected in our modern treatment techniques, technology and contemporary service experience. Our dedicated doctors and research team partner globally to be first movers in bringing clinical innovations to patients close to home. Around 30,000 people a year entrust us with their care across 50 locations nationally.
For more information please visit: www.genesiscare.com/au

Cirdan is a leading provider of healthcare informatics and imaging solutions designed to support and accelerate patient diagnosis. With operations in the United Kingdom, Australia and Canada, we are proud to support breast clinicians both across Australia and internationally.
We are committed to helping surgeons reduce re-operation rates through rapid, high-quality imaging at the point of care. Our solutions support both core biopsy and surgical specimen assessment, enabling faster clinical decision-making in theatres.
Solas OR delivers high-resolution imaging with seamless workflow integration, helping clinical teams manage cases accurately and efficiently.
For more information please visit: www.cirdan.com

MENTOR™ Australia, a business unit of Johnson & Johnson Medical Pty Ltd, is a global leader in breast aesthetics with a heritage dating back to 1969. With over 40 years dedicated to Breast Augmentation and Reconstruction innovation, MENTOR™ continues to advance science driven design, rigorous testing, and high quality implant solutions. The company supports surgeons through a patient first philosophy, offering extensive clinical evidence, trusted products, and professional education resources, including webinars and surgeon training through the Johnson & Johnson Institute. This commitment enables surgeons to deliver optimal, confident outcomes for their patients
For more information please visit: https://breastimplantsbymentor.net/en-AU/home

Veracyte is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development.
For more information please visit: www.veracyte.com/

Breast Cancer Network Australia (BCNA) is Australia’s leading breast cancer consumer organisation that has supported a network of over 250,000 people through breast cancer. As consumer led organisation, BCNA ensures the voices of lived experience is represented in breast cancer policy, research and service development. BCNA works with governments, health service providers, researchers, and the broader community to ensure that decisions and practices adopt patient-centred care.
For more information please visit: www.bcna.org.au

Novartis is improving the lives of more than 2.5 million patients across Australia and New Zealand through our medicines. By partnering with the healthcare system we are working for patients to address their needs, and we are committed to accelerating patient access to life saving treatments and associated healthcare.
We are reimagining medicine by using innovative science and technology to address challenging healthcare issues and our rich research pipeline has 50+ ongoing Phase III programs. We are transforming how clinical trials are run to increase patients’ access to our industry-leading clinical trials footprint in Australia.
For more information please visit: www.novartis.com/au-en/

So Brave is Australia’s only organisation dedicated specifically to supporting young women with breast cancer. We deliver education, advocacy, connection, and support for women diagnosed under 40, recognising that the experience of breast cancer is different for young women. Through awareness campaigns, peer support, community programs, and research funding, So Brave works to empower young women to be #breastaware, advocate for their health, and navigate diagnosis and treatment with strength and support.
For more information please visit: www.sobrave.org.au

Australia’s leader in Scar Camouflage and Paramedical Tattoo. With over a decade of experience, Paramedical Skin has restored thousands of scars, areolas, and pigment loss across Australia.
At Paramedical Skin, we have pioneered a scientifically informed Scar Camouflage Method, developed through years of rigorous testing. Unlike conventional scar tattooing, our approach is evidence-based, methodical, and customised, achieving results previously considered unattainable in scar concealment.
Trusted by Surgeons and Nurses nationwide and recommended by health professionals for complex scar and pigment restoration.
For more information please visit: www.paramedicalskin.com.au

Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer’s disease; providing solutions to some of the most debilitating immune system disorders; and broadening treatment options for cancer patients. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
For more information, please visit: www.lilly.com/au/

Medical Specialties Australasia (MSA) is a privately and wholly owned Australian medical device distribution company and is a leader in providing innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease.
MSA was founded in 1982 on the introduction of next-generation medical technology and has pioneered the establishment of many new medical and surgical technologies in the Australasia region over the last 41 years, including the first Vascular Access Port, Implantable Pump, PICC Line, AAA Stent Graft and Insulin Pump. Our diverse product lines for use in hospitals and private practices include surgical implants, venous ablation systems, vascular access products, colorectal surgery and diagnostic equipment, angiographic products and accessories, drainage products, thrombolytic products, and ENT consumables.
MSA’s core business strategy is to analyse long-term trends in health economics and international medical device markets, conduct extensive and precise market research, find the best technology internationally in our specialised fields which hold strong clinical and economical benefits, strategically align ourselves with like-minded medical device manufactures and then introduce new technologies to the Australasian market with regulatory and launching strategy expertise. As a distributor, we have the power to choose the products we represent, and we only select the best.
Many products in our range require high levels of clinical and technical support as the technology we introduce often requires a significant change in practice or procedure changing technique. Our customers receive comprehensive support through our highly trained field representatives, clinical educators, technical services specialists and customer service team and are committed to the continuous improvement of the services we provide.
For more information, please visit: www.msa.com.au/

Sorsix is a specialist digital health company delivering configurable, interoperable healthcare platforms that streamline clinical, administrative, and patient-facing workflows. Our flagship SaaS product, Pinga®, is a no code, modular health platform designed to digitise end to end patient pathways, automate referrals and scheduling, and enhance patient engagement. Built to integrate with national health infrastructure and third party systems, Pinga supports FHIR aligned interoperability and scalable deployments across local, state wide, and national health systems. Sorsix solutions are trusted by public healthcare organisations to reduce wait times, improve access to care, and deliver measurable operational and clinical outcomes.
For more information, please visit: www.sorsix.com

Inherited Cancers Australia (formerly Pink Hope) is the first and only national charity dedicated to supporting families at risk of inherited cancers. Since 2012, we have worked tirelessly to fill the gaps in support, education, and advocacy for those living with inherited cancer risk.
We empower people with information and understanding of inherited cancer to help them manage their cancer risk. We provide a supportive community for people to share their lived experiences. We fight inherited cancer with knowledge, transparency, and community. Most importantly we give people the confidence to assess their cancer risk. We offer a supportive community free from judgment, where all experiences are acknowledged and valued.
For more information, please visit: www.inheritedcancers.org.au

A New Generation Medical Device Company
Applied Medical designs, develops and manufactures innovative products that enable advanced surgical procedures and optimize patient outcomes. As a global medical device company, Applied Medical is equally committed to improving the affordability and accessibility of high-quality healthcare. We also further minimally invasive surgery by offering sophisticated training, including workshops, symposia and our simulation-based programs.
For more information, please visit:www.appliedmedical.com

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.
Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Based in Melbourne, Gilead Sciences Australia and New Zealand employs over 100 people.
For more information, please visit: www.gilead.com/en-au

Founded as the national training body for surgery in Ireland, The Royal College of Surgeons in Ireland (www.rcsi.ie) has been at the forefront of healthcare education since its establishment in 1784. Today, we are an innovative, world-leading international health sciences university and research institution offering education and training at Undergraduate, Postgraduate and Professional level.
For more information, please visit: www.ibccdublin.ie